Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
NeoGenomics Community
NasdaqCM:NEO Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
NeoGenomics
Popular
Undervalued
Overvalued
Community Investing Ideas
NeoGenomics
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
The Pathline Acquisition And NGS Expansion Will Open New Markets
Key Takeaways NeoGenomics' strategic expansions and acquisitions drive significant revenue growth and market access improvements in key regions. Focus on next-generation sequencing and strategic collaborations enhances revenue, operational efficiencies, and potential growth opportunities.
View narrative
US$14.35
FV
46.3% undervalued
intrinsic discount
12.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
NEO
NEO
NeoGenomics
Your Fair Value
US$
Current Price
US$7.70
12.9% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-126m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.1b
Earnings US$83.6m
Advanced
Set Fair Value